|
|
| Line 6: |
Line 6: |
| | ===Applications of BBa_K1372001=== | | ===Applications of BBa_K1372001=== |
| | | | |
| − | In order to characterize the biobrick, the team iGEM Paris Saclay 2016 tested the color switch system (BBa_K13372001) on three different constructions, contained in the plasmid [[Team:Paris_Saclay/Experiments#pclTQ|pcl99]]:
| |
| − | * [[Team:Paris_Saclay/Experiments#pclTQ|TAA]]: LacZ and Luc coding sequences in the same open reading frame, separated with an ochre stop codon.
| |
| − | * [[Team:Paris_Saclay/Experiments#pclTQ|TQ]]: LacZ and Luc coding sequences in the same open reading frame.
| |
| − | * [[Team:Paris_Saclay/Experiments#pclTQ|TAG]]: LacZ and Luc coding sequences in the same open reading frame, separated with an amber stop codon.
| |
| − | Each condition was tested under three different salicylate concentrations. In order to achieve that, both measurements of Beta-Galactosidase and Luciferase activities were performed on bacteria cultures <b>[Fig. 1]</b>.
| |
| − |
| |
| − | The experiment was conducted on three sets of cultures of bacteria:
| |
| − |
| |
| − | * TAA: BL21|pSB1C3_BBa_K1372001 and pcl_TAA
| |
| − | * TQ: BL21|pSB1C3_BBa_K1372001 and pcl_Tq
| |
| − | * TAG: BL21|pSB1C3_BBa_K1372001 and pcl_TAG
| |
| − | Each of those sets of culture were incubated with three different salicylate concentrations: 0, 30µM and 1mM.
| |
| − |
| |
| − | Three clones (clones 1, 2 or 3) were tested for each condition, with three different salicylate concentrations (0, 30µM or 1mM), with in addition a negative control sample.
| |
| − |
| |
| − | pcl_TAA construction contains a TAA stop codon between LacZ and Luc. This codon is not recognized by the supD suppressor t-RNA : no luciferase activity is expected.
| |
| − | pcl_Tq construction does not contain any stop codon : the luciferase activity is expected to be at the maximal.
| |
| − | pcl_TAG contains the TAG codon recognized by supD suppressor t-RNA : the expression of luciferase should be inducible by salicylate.
| |
| − |
| |
| − | [[File:T--Paris Saclay--20161015 characterizationk1372001.png|400px|centre|]]
| |
| − | <center><b>Figure 1:</b> Explanatory diagram of the characterization. pcl_TAA construction contains a TAA stop codon between LacZ and Luc. pcl_Tq construction does not contain any stop codon. pcl_TAG contains the TAG codon recognized by supD suppressor t-RNA.</center>
| |
| − |
| |
| − |
| |
| − | The luciferase luminescence is expected to vary depending to the different constructions conditions and to salicylate concentrations, instead of the Beta Galactosidase activity, which will remain constant. Thus luciferase data were normalized with those from Beta Galactosidase and our results are expressed as the Luciferase/Beta-Galactosidase activity. This ratio is independent of the level of transcription, initiation or mRNA stability.
| |
| − |
| |
| − | [[File:T--Paris_Saclay--activity_Luc_Gal_Tq_fonction_salicylate2.PNG|400px|centre|]]
| |
| − | <center><b>Figure 2:</b> Luciferase activity with TQ construction depending of salicylate concentration. 3 clones were tested per condition. Luciferase activity depends on the transcription of pclTAA.</center>
| |
| − |
| |
| − | The Tq plasmid does not contain any stop codon between LacZ and Luc. Thus, no matter the salicylate concentration, both Luciferase and Beta Galactosidase activities are supposed to be detected.
| |
| − | As expected a high level of Luciferase/bGal activity is observed, but the ratio decreases when salicylate concentration increases <b>[Fig. 2]</b>. Indeed, both activities of Luciferase and bGal drop from 30µM of salicylate, but luciferase activity was more affected by the salicylate than bGal one.
| |
| − | One may hypothesize that salicylate inhibits differently both reporter proteins activities, with a stronger inhibition of luciferase activity. We cannot determine whether this inhibition is due to a physiological consequence onto bacteria metabolism or occures after protein extraction.
| |
| − |
| |
| − | In order to read the next results, we calculated a readthrough percentage, by doing a ratio between luciferase/bGal from TAA or TAG constructs and luciferase/bGal from TQ. Thus, we obtain a readthrough percentage.
| |
| − |
| |
| − | [[File:T--Paris_Saclay--activity_Luc_Gal_TAA_fonction_salicylate2.PNG|400px|centre|]]
| |
| − | <center><b>Figure 3:</b> Luciferase activity with TAA construction depending of salicylate concentration. 3 clones were tested per condition. Luciferase activity depends on the expression and capacity of the suppressor t-RNA to read TAA codon.</center>
| |
| − |
| |
| − |
| |
| − | In TAA condition, regardless of the salicylate concentration, there is no significant Luciferase activity, so the ratio remains very low at any concentrations <b>[Fig. 3]</b>.
| |
| − | We conclude that supD suppressor tRNA is very specific of the TAG codon and has no impact on the TAA stop codon.
| |
| − |
| |
| − | [[File:T--Paris_Saclay--activity_Luc_Gal_TAG_fonction_salicylate2.PNG|400px|centre|]]
| |
| − | <center><b>Figure 4:</b> Luciferase activity with TAG construction depending of salicylate concentration. 3 clones were tested per condition. Luciferase activity depends on the expression and capacity of the suppressor t-RNA to read TAG codon.</center>
| |
| − |
| |
| − |
| |
| − | In TAG condition we can see an increase of stop codon readthrough activity with the increase of the salicylate concentration <b>[Fig. 4]</b>.
| |
| − | In comparison to the results obtained with the TAA construction, the readthrough level increases similarly to the concentration of salicylate.
| |
| − | This indicates that TAG stop codon is efficiently readthrough in presence of supD tRNA, allowing the production of a significant amount of luciferase.
| |
| − |
| |
| − | In conclusion, the Psal promoter is fully inducible by salicylate and the suppressor tRNA is functional to suppress the TAG codon. These experiments demonstrate that the BBa_K1372001 biobrick is fully functional.
| |
| | | | |
| | ===User Reviews=== | | ===User Reviews=== |
UNIQ0e9b8824d510d7a1-partinfo-00000000-QINU
UNIQ0e9b8824d510d7a1-partinfo-00000001-QINU
